Gletmet-PG2 Tablet PR
Marketer
Kaymed Pharmaceuticals Pvt. Ltd.
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Gletmet-PG2 Tablet PR
Combiflor-DP2 tablets manage blood glucose levels in adults with type 2 diabetes. Used alongside diet and exercise, this dual-action medication enhances insulin effectiveness, reducing blood sugar. Follow your physician's prescribed dosage and regimen; take with food to minimize stomach discomfort. If a dose is missed, take it promptly unless the next dose is imminent; never double the dose. Overdosing can cause dangerously low blood sugar (hypoglycemia). Concomitant use with other diabetes medications, alcohol, or skipped meals raises hypoglycemia risk; regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Inform your doctor about kidney, liver, or heart conditions before use; pregnant or breastfeeding individuals should seek medical advice. Kidney function tests are typically performed prior to initiating treatment. Limit alcohol consumption as it can heighten the risk of side effects.
Uses of Gletmet-PG2 Tablet PR
Managing type 2 diabetes
Major Benefits of Gletmet-PG2 Tablet PR:
Follow your doctor's instructions or consult the product label for usage guidelines. Administer Gletmet-PG2 Tablet PR with food.
Common Side effects of Gletmet-PG2 Tablet PR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Gletmet-PG2 Tablet PR:
Follow your physician's instructions or consult the product information leaflet for dosage guidance. Administer Gletmet-PG2 Tablet PR with food.
How Gletmet-PG2 Tablet PR works:
Gletmet-PG2 Tablet PR combines three distinct antidiabetic agents—glimepiride, metformin, and pioglitazone—to optimize blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, acts via multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Gletmet-PG2 Tablet PR is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Gletmet-PG2 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Gletmet-PG2 Tablet PR use are likely incompatible. Available human data indicates potential drug transfer via breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms appear.
KidneyCAUTION
Patients with kidney impairment should use Gletmet-PG2 Tablet PR cautiously, potentially requiring dosage modification. Consult your physician. Gletmet-PG2 Tablet PR is contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Gletmet-PG2 Tablet PR cautiously, potentially requiring dosage modification under medical supervision. Gletmet-PG2 Tablet PR is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Gletmet-PG2 Tablet PR :
Should you forget a dose of Gletmet-PG2 Tablet PR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Gletmet-PG2 Tablet PR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently